Showing results (611-620 of 671) with videos related to

Sort By:
Pageof 68
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.
Cancers|December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung CancerHui Li, Lingzhi Hong, Pedro Rocha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 12, 2017
Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in LungAndrew G Nicholson, Kathleen Torkko, Patrizia Viola, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 25, 2026
Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen ExposureBo Zhu, Muhammad Aminu, Pingjun Chen, et al.
Cancer Research|February 3, 2016
STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor MicroenvironmentShohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine CarcinomaMinglei Zhuo, Yanfang Guan, Xue Yang, et al.
Cell Reports|April 21, 2021
Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneityNeus Bota-Rabassedas, Priyam Banerjee, Yichi Niu, et al.
Oncoimmunology|May 4, 2016
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanomaZachary A Cooper, Alexandre Reuben, Christine N Spencer, et al.
Journal for Immunotherapy of Cancer|January 8, 2025
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharingJanis M Taube, Joel C Sunshine, Michael Angelo, et al.
Cancer Discovery|June 13, 2015
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesFerdinandos Skoulidis, Lauren A Byers, Lixia Diao, et al.
Pageof 68